Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries
about
Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature reviewImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumTreatment options and outcomes for glioblastoma in the elderly patientThe epidemiology of glioma in adults: a "state of the science" reviewThe role of imaging in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.A Surveillance, Epidemiology and End Results-Medicare data analysis of elderly patients with glioblastoma multiforme: Treatment patterns, outcomes and costHost mediated inflammatory influence on glioblastoma multiforme recurrence following high-dose ionizing radiation.Odds of death after glioblastoma diagnosis in the United States by chemotherapeutic era.Arginine-rich, cell penetrating peptide-anti-microRNA complexes decrease glioblastoma migration potential.Hospitalization burden and survival among older glioblastoma patients.Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.Saponin 1 induces apoptosis and suppresses NF-κB-mediated survival signaling in glioblastoma multiforme (GBM).Charged group surface accessibility determines micelleplexes formation and cellular interaction.Brain tumor classification using the diffusion tensor image segmentation (D-SEG) techniqueTreatment results of glioblastoma during the last 30 years in a single instituteExtracellular RNAs: development as biomarkers of human disease.Effect of pretreatment clinical factors on overall survival in glioblastoma multiforme: a Surveillance Epidemiology and End Results (SEER) population analysis.Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)Neurosurgery concepts: Key perspectives on regulatory proteins, management of ossification of the posterior longitudinal ligament, and radiosurgery for intracranial lesionsPatterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in SpainTime trends in glioblastoma multiforme survival: the role of temozolomide.Antivascular endothelial growth factor antibody for treatment of glioblastoma multiformeAutomated Segmentation of Hyperintense Regions in FLAIR MRI Using Deep Learning.Cancer stem cells from human glioblastoma resemble but do not mimic original tumors after in vitro passaging in serum-free media.Glioblastoma multiforme outcomes of 107 patients treated in two Singapore institutions.A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.Introduction, rationale, and methodology.The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of neuropathology in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of targeted therapies in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Survival benefit of glioblastoma patients after FDA approval of temozolomide concomitant with radiation and bevacizumab: A population-based study.Methylation regulates HEY1 expression in glioblastomaOTX015 (MK-8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models.ExRNA in Biofluids as Biomarkers for Brain Tumors.Targeting the VEGF and PDGF signaling pathway in glioblastoma treatment.Stem cell-based therapies for tumors in the brain: are we there yet?Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells
P2860
Q26739012-663A714D-D672-4CD1-AA40-AAC1A6758CDFQ26765459-0108F7B2-347D-4C54-9895-7FC590AE68ABQ26991605-9D7BE7B7-D430-4EC7-95D4-3EB0D86B1C5BQ28387839-36742676-5663-40DC-B9BF-9B48C825A346Q30797166-24BA9AE4-631F-40D3-B1FA-A2B4B6FAD728Q31029542-C4CBFE38-923E-4E14-BA63-FDF1E62F1E43Q33713130-E97AF3DF-CE4F-4067-9404-D0243D6C604CQ33913598-C97A9C7A-E3DD-4292-A01F-90497979B688Q34032623-DB7C50C4-CA17-4840-A3AC-C5F191AC572AQ34359639-1C5668BE-A933-45C2-B750-BD4725B9CEE9Q34775318-08B60DA3-1FC8-4A03-95DC-A929D49ED160Q35053956-B05F0D9C-F45A-4720-B8CB-8980EEEC9F93Q35776325-0145D314-8732-42F2-AC21-0CB8F7749BEAQ35788877-CE5CABB5-FE56-4DB3-9BF5-440C2441FF71Q35869502-EA06123C-C9C1-4615-8C22-F7D0AB422AACQ36006446-DF411A10-7BE8-4B26-9AC5-7C98648BF297Q36411906-A25CAE02-193A-40C8-A847-3FD52D6600F7Q36500411-4B8EFD75-3797-4CD0-9E52-6E235A0410EFQ36754942-F7153139-C956-494B-BC2E-5FA1F7007ACEQ36866021-356267F8-B3EC-4F75-A304-7DAE6346CF43Q37312701-144A8F5C-203B-4BDB-A5B6-27C1B2C80660Q37372416-AA644434-80F2-4AAD-91EF-2565BD35D682Q37561820-046AE195-BB57-4A07-B8F6-9764656D4ABAQ37662331-B41BF2E7-04F7-4EE2-8E43-C516E93BC516Q37672546-47698BF2-9FF2-44BB-81CA-B5CF1E0E9C12Q37675804-D5F37982-F279-454D-B64A-EB9C3674605CQ38203242-102371B4-FE1F-45B6-A6F6-5EDCE64CBAF3Q38204289-E31F2001-24CC-432F-946C-EC18524209EEQ38204718-89F275D4-6909-4111-AD07-0979CA6B6C89Q38205133-29E3FFF9-0AEB-4E81-94E7-45B170163B0FQ38205134-45D74684-D5C9-4B04-8949-49B97E90202CQ38206395-243B9540-BD20-45F0-A1C3-3169139ADB3AQ38255481-ABF6D3F6-1A9A-4EF5-B2D5-E5C48545DB88Q38401201-EE96645A-7477-492E-A804-F70617107052Q38675672-8415F7A8-3170-438F-BF85-29B1A4BB385FQ38759279-6CA2643B-63CF-4B64-8830-DC7CEF0C1CE2Q38781031-F41EA835-41F4-4E5D-BCA8-D1E893012056Q38838030-FAB020C8-E657-4E81-94C0-53593A894464Q38855638-6123581B-5127-4DB2-B873-5F93E03ECAEBQ38865979-6D908DC8-9BA8-4F38-8838-58B081C7F228
P2860
Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Adult glioblastoma multiforme ...... gy, and End Results registries
@ast
Adult glioblastoma multiforme ...... gy, and End Results registries
@en
type
label
Adult glioblastoma multiforme ...... gy, and End Results registries
@ast
Adult glioblastoma multiforme ...... gy, and End Results registries
@en
prefLabel
Adult glioblastoma multiforme ...... gy, and End Results registries
@ast
Adult glioblastoma multiforme ...... gy, and End Results registries
@en
P2093
P2860
P356
P1433
P1476
Adult glioblastoma multiforme ...... gy, and End Results registries
@en
P2093
Amy S Darefsky
Joseph T King
Robert Dubrow
P2860
P304
P356
10.1002/CNCR.26494
P407
P577
2011-08-31T00:00:00Z